Pharmaceutical composition

  • US 9,555,027 B2
  • Filed: 10/10/2014
  • Issued: 01/31/2017
  • Est. Priority Date: 05/26/2005
  • Status: Active Grant
First Claim
Patent Images

1. An oral preparation, comprising:

  • N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-(2R,3R)-2,3-tetramethylene-butyl]-(1′

    R,2′

    S,3′

    R,4′

    S)-2,3-bicyclo[2,2,1]heptanedicarboxyimide hydrochloride (lurasidone) of formula (1);

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×